Volume : 11, Issue : 02, February – 2024
Title:
A REVIEW ARTICLE ON GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Authors :
S C Zaiba Arshia , S Shaheena Begum
Abstract :
Gastroesophageal reflux disease (GERD) is a common clinical problem, affecting millions of people worldwide. Patients are recognized by both classic and atypical symptoms. Acid suppressive therapy provides symptomatic relief and prevents complications in many individuals with GERD. Advances in diagnostic and therapeutic modalities have improved our ability to identify and manage disease complications. Here, we discuss the pathophysiology and effects of GERD, and provide information on the clinical approach to this common disorder. Introduction Symptoms and complications that result from the reflux of stomach contents Gastroesophageal reflux disease (GERD) is a very common digestive disorder worldwide with an estimated prevalence of 18.1–27.8% in North America.Approximately half of all adults will report reflux symptoms at some time. According to the Montreal definition, GERD is a condition of troublesome synts into the esophagus. Diagnosis of GERD is typically based on classic symptoms and response to acid suppression after an empiric trial. GERD is an important health concern as it is associated with decreased quality of life and significant morbidity. Successful treatment of GERD symptoms has been associated with significant improvement in quality of life, including decreased physical pain, increased vitality, physical and social function, and emotional well-being. While GERD medications are not particularly expensive, the cost of treating GERD patients has been deemed 2-fold more costly than comparable individuals without GERD.This cost difference is likely due to higher morbidity in GERD patients and the higher cost of managing complications of inappropriately treated GERD.
Cite This Article:
Please cite this article in press S C Zaiba Arshia et al., A Review Article On Gastroesophageal Reflux Disease (GERD), Indo Am. J. P. Sci, 2024; 11 (02).
Number of Downloads : 10
References:
1. Chhabra P, Ingole N (August 29, 2022) Gastroesophageal Reflux Disease (GERD): Highlighting Diagnosis, Treatment, and Lifestyle Changes. Cureus 14(8): e28563. doi:10.7759/cureus.28563 45 Danisa M.Clarrett, MDDanisa M. Clarrett, MD, MS, is a Fellow in the Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, Mo.Christine Hachem, MD Christine Hachem, MD, is an Associate Professor of Internal Medicine, Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis,
2. Byron australian herbalist gut health support byronherbalist.com
3. Textbook of Pharmacotherapy [a pathophysiologic approach] 6th edition by Joseph T.Dipiro, Robert L.Talbert, Gary R.Matzke, Barbara G.Wells, L.Micheal Posey.
4. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63:871–880.
5. Locke GR, 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ., 3rd Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448–1456.
6. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920.
7. Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med. 1998;104:252–258.
8. Bloom BS, Jayadevappa R, Wahl P, Cacciamanni J. Time trends in cost of caring for people with gastroesophageal reflux disease. Am J Gastroenterol. 2001;96:S64–69.
9. Zheng Z, Nordenstedt H, Pedersen NL, Lagergren J, Ye W. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology. 2007;132:87–95
10. Jarosz M, Taraszewska A. Risk factors for gastroesophageal reflux disease: the role of diet. Prz Gastroenterol. 2014;9:297–301.
11. Ferriolli E, Oliveira RB, Matsuda NM, Braga FJ, Dantas RO. Aging, esophageal motility, and gastroesophageal reflux. J Am Geriatr Soc. 1998;46:1534–1537.
12. Emerenziani S, Zhang X, Blondeau K, Silny J, Tack J, Janssens J, et al. Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux. Am J Gastroenterol. 2005;100:1251–1256.
13. Herregods TV, Bredenoord AJ, Smout AJ. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. Neurogastroenterol Motil. 2015;27:1202–1213.
14. Richter JE. Gastroesophageal reflux disease in the older patient: presentation, treatment, and complications. Am J Gastroenterol. 2000;95:368–373. 12. Bredenoord AJ, Weusten BL, Curvers WL, Timmer R, Smout AJ. Determinants of perception of heartburn and regurgitation. Gut. 2006;55:313–318.
15. Gastal OL, Castell JA, Castell DO. Frequency and site of gastroesophageal reflux in patients with chest symptoms. Studies using proximal and distal pH monitoring. Chest. 1994;106:1793–1796.
16. Tokashiki R, Funato N, Suzuki M. Globus sensation and increased upper esophageal sphincter pressure with distal esophageal acid perfusion. Eur Arch Otorhinolaryngol. 2010;267:737–741.
17. Irwin RS, French CL, Curley FJ, Zawacki JK, Bennett FM. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest. 1993;104:1511–1517.
18. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–328.
19. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40:275–285
20. Shaheen NJ, Richter JE. Barrett’s oesophagus. Lancet. 2009;373:850–861.
21. Khademi H, Radmard AR, Malekzadeh F, Kamangar F, Nasseri-Moghaddam S, Johansson M, et al. Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in patients with dyspepsia in a GI clinic: a 7-year cross-sectional study. PLoS One. 2012;7:e39173.
22. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004;53(Suppl 4):iv1–24.
23. Wang WH, Huang JQ, Zheng GF, Wong WM, Lam SK, Karlberg J, et al. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis. Arch Intern Med. 2005;165:1222–1228.
24. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–180.
25. Wiener GJ, Morgan TM, Copper JB, Wu WC, Castell DO, Sinclair JW, et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci. 1988;33:1127–1133.
26. Sethi S, Richter JE
27. Commisso A, Lim F Crit Care Nurs Q. 2019, 42:64-74.
28. Dağlı Ü, Kalkan İH: The role of lifestyle changes in gastroesophageal reflux diseases treatment. Turk J Gastroenterol. 2017, 28:33-7.
29. Orenstein SR: Gastroesophageal reflux. Pediatr Rev. 1999, 20:24-8. Clarrett DM, Hachem C:. Mo Med. 2018, 115:214-8.